Add to ORKG[[sponsorship]]植物暨微生物學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1535-3893&DestApp=JCR&RQ=IF_CAT_BOXPLOT[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=RID&SrcApp=RID&DestLinkType=FullRecord&DestApp=ALL_WOS&KeyUT=00027326790002
The current therapy for ovarian cancer has advanced from alkylating agents, to a combination of carb...
BACKGROUND: Less than 50% of ovarian cancers respond to paclitaxel. Effective strategies are needed ...
Background: The taxane paclitaxel (Taxol) is often of limited efficacy in chemotherapeutic regimens ...
[[sponsorship]]農業生物科技研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway...
Paclitaxel (PTX) is a widely used chemotherapeutic drug effective against numerous cancers. To eluci...
Breast cancer; Predictive markers; Proteomic analysisCáncer de mama; Marcadores predictivos; Análisi...
Precision oncology research is challenging outside the contexts of oncogenic addiction and/or target...
Multiple Phos-tag-based screens were conducted in anti-tubulin drug (paclitaxel and nocodazole)-trea...
OBJECTIVE:To identify the proteins involved the compensatory adaptive response to paclitaxel in ovar...
[[sponsorship]]生物化學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
[[sponsorship]]生物化學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
The current therapy for ovarian cancer has advanced from alkylating agents, to a combination of carb...
In drug discovery and development, characterization of the drug targets and mechanisms of action is ...
Deconvolution of targets and action mechanisms of anticancer compounds is fundamental in drug develo...
The current therapy for ovarian cancer has advanced from alkylating agents, to a combination of carb...
BACKGROUND: Less than 50% of ovarian cancers respond to paclitaxel. Effective strategies are needed ...
Background: The taxane paclitaxel (Taxol) is often of limited efficacy in chemotherapeutic regimens ...
[[sponsorship]]農業生物科技研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway...
Paclitaxel (PTX) is a widely used chemotherapeutic drug effective against numerous cancers. To eluci...
Breast cancer; Predictive markers; Proteomic analysisCáncer de mama; Marcadores predictivos; Análisi...
Precision oncology research is challenging outside the contexts of oncogenic addiction and/or target...
Multiple Phos-tag-based screens were conducted in anti-tubulin drug (paclitaxel and nocodazole)-trea...
OBJECTIVE:To identify the proteins involved the compensatory adaptive response to paclitaxel in ovar...
[[sponsorship]]生物化學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
[[sponsorship]]生物化學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Ga...
The current therapy for ovarian cancer has advanced from alkylating agents, to a combination of carb...
In drug discovery and development, characterization of the drug targets and mechanisms of action is ...
Deconvolution of targets and action mechanisms of anticancer compounds is fundamental in drug develo...
The current therapy for ovarian cancer has advanced from alkylating agents, to a combination of carb...
BACKGROUND: Less than 50% of ovarian cancers respond to paclitaxel. Effective strategies are needed ...
Background: The taxane paclitaxel (Taxol) is often of limited efficacy in chemotherapeutic regimens ...